Industry: Service & Software
Published Date: 2026-01-14
Pages: 101 Pages
Report ld: 5661313
Request Sample
Customized Report
The global Personalized Psychiatry market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Personalized Psychiatry is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Personalized Psychiatry is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Personalized Psychiatry in Mental Health Professionals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Personalized Psychiatry include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica, Akili Interactive, Neuroverse, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Personalized Psychiatry market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Personalized Psychiatry. The Personalized Psychiatry market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Personalized Psychiatry market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Personalized Psychiatry manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Personalized Psychiatry companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Psychiatry Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Depression and Anxiety
1.2.3 Bipolar Disorder
1.2.4 Addiction
1.2.5 Other
1.3 Market by Application
1.3.1 Global Personalized Psychiatry Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Mental Health Professionals
1.3.3 Patients
1.3.4 Healthcare Providers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Psychiatry Market Perspective (2021–2032)
2.2 Global Personalized Psychiatry Growth Trends by Region
2.2.1 Global Personalized Psychiatry Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Personalized Psychiatry Historic Market Size by Region (2021–2026)
2.2.3 Personalized Psychiatry Forecasted Market Size by Region (2027–2032)
2.3 Personalized Psychiatry Market Dynamics
2.3.1 Personalized Psychiatry Industry Trends
2.3.2 Personalized Psychiatry Market Drivers
2.3.3 Personalized Psychiatry Market Challenges
2.3.4 Personalized Psychiatry Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Psychiatry Players by Revenue
3.1.1 Global Top Personalized Psychiatry Players by Revenue (2021–2026)
3.1.2 Global Personalized Psychiatry Revenue Market Share by Players (2021–2026)
3.2 Global Top Personalized Psychiatry Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Personalized Psychiatry Revenue
3.4 Global Personalized Psychiatry Market Concentration Ratio
3.4.1 Global Personalized Psychiatry Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Psychiatry Revenue in 2025
3.5 Global Key Players of Personalized Psychiatry Head Offices and Areas Served
3.6 Global Key Players of Personalized Psychiatry, Products and Applications
3.7 Global Key Players of Personalized Psychiatry, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Personalized Psychiatry Breakdown Data by Type
4.1 Global Personalized Psychiatry Historic Market Size by Type (2021–2026)
4.2 Global Personalized Psychiatry Forecasted Market Size by Type (2027–2032)
5 Personalized Psychiatry Breakdown Data by Application
5.1 Global Personalized Psychiatry Historic Market Size by Application (2021–2026)
5.2 Global Personalized Psychiatry Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Personalized Psychiatry Market Size (2021–2032)
6.2 North America Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Personalized Psychiatry Market Size by Country (2021–2026)
6.4 North America Personalized Psychiatry Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Psychiatry Market Size (2021–2032)
7.2 Europe Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Personalized Psychiatry Market Size by Country (2021–2026)
7.4 Europe Personalized Psychiatry Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Personalized Psychiatry Market Size (2021–2032)
8.2 Asia-Pacific Personalized Psychiatry Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Personalized Psychiatry Market Size by Region (2021–2026)
8.4 Asia-Pacific Personalized Psychiatry Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Personalized Psychiatry Market Size (2021–2032)
9.2 Latin America Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Personalized Psychiatry Market Size by Country (2021–2026)
9.4 Latin America Personalized Psychiatry Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Psychiatry Market Size (2021–2032)
10.2 Middle East & Africa Personalized Psychiatry Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Personalized Psychiatry Market Size by Country (2021–2026)
10.4 Middle East & Africa Personalized Psychiatry Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 COMPASS Pathways
11.1.1 COMPASS Pathways Company Details
11.1.2 COMPASS Pathways Business Overview
11.1.3 COMPASS Pathways Personalized Psychiatry Introduction
11.1.4 COMPASS Pathways Revenue in Personalized Psychiatry Business (2021–2026)
11.1.5 COMPASS Pathways Recent Development
11.2 Mindstrong Health
11.2.1 Mindstrong Health Company Details
11.2.2 Mindstrong Health Business Overview
11.2.3 Mindstrong Health Personalized Psychiatry Introduction
11.2.4 Mindstrong Health Revenue in Personalized Psychiatry Business (2021–2026)
11.2.5 Mindstrong Health Recent Development
11.3 Pear Therapeutics
11.3.1 Pear Therapeutics Company Details
11.3.2 Pear Therapeutics Business Overview
11.3.3 Pear Therapeutics Personalized Psychiatry Introduction
11.3.4 Pear Therapeutics Revenue in Personalized Psychiatry Business (2021–2026)
11.3.5 Pear Therapeutics Recent Development
11.4 Cogito
11.4.1 Cogito Company Details
11.4.2 Cogito Business Overview
11.4.3 Cogito Personalized Psychiatry Introduction
11.4.4 Cogito Revenue in Personalized Psychiatry Business (2021–2026)
11.4.5 Cogito Recent Development
11.5 Kaia Health
11.5.1 Kaia Health Company Details
11.5.2 Kaia Health Business Overview
11.5.3 Kaia Health Personalized Psychiatry Introduction
11.5.4 Kaia Health Revenue in Personalized Psychiatry Business (2021–2026)
11.5.5 Kaia Health Recent Development
11.6 Sooma
11.6.1 Sooma Company Details
11.6.2 Sooma Business Overview
11.6.3 Sooma Personalized Psychiatry Introduction
11.6.4 Sooma Revenue in Personalized Psychiatry Business (2021–2026)
11.6.5 Sooma Recent Development
11.7 GenoMind
11.7.1 GenoMind Company Details
11.7.2 GenoMind Business Overview
11.7.3 GenoMind Personalized Psychiatry Introduction
11.7.4 GenoMind Revenue in Personalized Psychiatry Business (2021–2026)
11.7.5 GenoMind Recent Development
11.8 Empatica
11.8.1 Empatica Company Details
11.8.2 Empatica Business Overview
11.8.3 Empatica Personalized Psychiatry Introduction
11.8.4 Empatica Revenue in Personalized Psychiatry Business (2021–2026)
11.8.5 Empatica Recent Development
11.9 Akili Interactive
11.9.1 Akili Interactive Company Details
11.9.2 Akili Interactive Business Overview
11.9.3 Akili Interactive Personalized Psychiatry Introduction
11.9.4 Akili Interactive Revenue in Personalized Psychiatry Business (2021–2026)
11.9.5 Akili Interactive Recent Development
11.10 Neuroverse
11.10.1 Neuroverse Company Details
11.10.2 Neuroverse Business Overview
11.10.3 Neuroverse Personalized Psychiatry Introduction
11.10.4 Neuroverse Revenue in Personalized Psychiatry Business (2021–2026)
11.10.5 Neuroverse Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Personalized Psychiatry market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 121
USD 4900.00
(Single User License)
The global Personalized Psychiatry market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 78
USD 4250.00
(Single User License)
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 89
USD 3950.00
(Single User License)
The global Personalized Psychiatry market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 76
USD 4250.00
(Single User License)
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 126
USD 4900.00
(Single User License)
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 84
USD 3950.00
(Single User License)
The global market for Personalized Psychiatry was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 80
USD 2900.00
(Single User License)
The global Personalized Psychiatry revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-08-01
Pages: 93
USD 4350.00
(Single User License)
The global Personalized Psychiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-08-01
Pages: 71
USD 2900.00
(Single User License)
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-08-01
Pages: 128
USD 4900.00
(Single User License)
The global Personalized Psychiatry market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 121
The global Personalized Psychiatry market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 78
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 89
The global Personalized Psychiatry market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 76
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 126
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 84
The global market for Personalized Psychiatry was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 80
The global Personalized Psychiatry revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-08-01
Pages: 93
The global Personalized Psychiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-08-01
Pages: 71
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-08-01
Pages: 128
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now